ES2000034A6 - Procedimiento para la preparacion de una vacuna viva contra paperas - Google Patents

Procedimiento para la preparacion de una vacuna viva contra paperas

Info

Publication number
ES2000034A6
ES2000034A6 ES8600325A ES8600325A ES2000034A6 ES 2000034 A6 ES2000034 A6 ES 2000034A6 ES 8600325 A ES8600325 A ES 8600325A ES 8600325 A ES8600325 A ES 8600325A ES 2000034 A6 ES2000034 A6 ES 2000034A6
Authority
ES
Spain
Prior art keywords
seen
vaccine against
preparing
living vaccine
against mumps
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8600325A
Other languages
English (en)
Inventor
Reinhard Gluck
Rene Germanier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cilag GmbH International
Original Assignee
Schweiz Serum und Impfinstitut und Institut zur Erforschung der Infektionskrankheiten
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schweiz Serum und Impfinstitut und Institut zur Erforschung der Infektionskrankheiten filed Critical Schweiz Serum und Impfinstitut und Institut zur Erforschung der Infektionskrankheiten
Publication of ES2000034A6 publication Critical patent/ES2000034A6/es
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/155Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/165Mumps or measles virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0015Combination vaccines based on measles-mumps-rubella
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5254Virus avirulent or attenuated
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18411Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

EL INVENTO CONCIERNE AL PROCEDIMIENTO PARA LA PREPARACION DE UNA VACUNA VIVA CONTRA PAPERAS, CARACTERIZADO PORQUE VIRUS OBTENIDOS A PARTIR DE LA ORINA DE PACIENTES DE PAPERAS AGUDAMENTE ENFERMOS, SE SIGUEN CULTIVANDO SOBRE TEJIDO HUMANO DIPLOIDE, SE ATENUAN POR PASADAS REPETIDAS EN DICHO TEJIDO Y EN HUEVOS DE GALLINAS EMBRIONADOS, SE ATENUAN ADICIONALMENTE POR PASADAS ADICIONALES EN TEJIDO HUMANO DIPLOIDE Y CON ELLO SE ADAPTAN A TEJIDO HUMANO, SE AISLAN, DESPUES DE ELLO SE CULTIVAN Y SE TRANSFORMAN EN LA VACUNA VIVA.
ES8600325A 1985-11-26 1986-07-16 Procedimiento para la preparacion de una vacuna viva contra paperas Expired ES2000034A6 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH506285 1985-11-26
CH13386 1986-01-15

Publications (1)

Publication Number Publication Date
ES2000034A6 true ES2000034A6 (es) 1987-10-01

Family

ID=25683616

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8600325A Expired ES2000034A6 (es) 1985-11-26 1986-07-16 Procedimiento para la preparacion de una vacuna viva contra paperas

Country Status (8)

Country Link
US (1) US5006335A (es)
EP (1) EP0223915B1 (es)
AU (1) AU586299B2 (es)
CA (1) CA1286226C (es)
DE (1) DE3676960D1 (es)
ES (1) ES2000034A6 (es)
PT (1) PT83544B (es)
YU (1) YU46029B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2059692C (en) * 1991-01-28 2004-11-16 Peter J. Kniskern Pneumoccoccal polysaccharide conjugate vaccine
US6022726A (en) * 1992-02-03 2000-02-08 Palese; Peter Genetically engineered attenuated viruses
US6316243B1 (en) 1992-04-14 2001-11-13 Peter Palese Genetically engineered attenuated double-stranded RNA viruses
US5728386A (en) * 1993-12-21 1998-03-17 Merck & Co., Inc. Thermostable varicella zoster virus
US6872547B1 (en) 2000-10-11 2005-03-29 Washington University Functional balanced-lethal host-vector systems

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3514374A (en) * 1968-04-02 1970-05-26 Merck & Co Inc Method of purification of myxovirus vaccine
US3555149A (en) * 1968-07-05 1971-01-12 Merck & Co Inc Mumps vaccine and its preparation
JPS528379B1 (es) * 1971-04-30 1977-03-09
US3961046A (en) * 1974-12-02 1976-06-01 American Cyanamid Company Mumps vaccine and preparation thereof
JPS55147227A (en) * 1979-05-04 1980-11-17 Handai Biseibutsubiyou Kenkyukai Preparrtion of attenuated live mumps vaccine
IL86180A (en) * 1987-05-04 1992-08-18 Merck & Co Inc Stable lyophilized live herpes virus vaccine and such a vaccine combined with other virus vaccines

Also Published As

Publication number Publication date
AU6579486A (en) 1987-05-28
EP0223915A3 (en) 1989-05-17
PT83544A (fr) 1986-11-01
CA1286226C (en) 1991-07-16
EP0223915A2 (de) 1987-06-03
YU46029B (sh) 1992-12-21
US5006335A (en) 1991-04-09
DE3676960D1 (de) 1991-02-21
YU196986A (en) 1988-10-31
EP0223915B1 (de) 1991-01-16
PT83544B (pt) 1988-11-30
AU586299B2 (en) 1989-07-06

Similar Documents

Publication Publication Date Title
NO890089D0 (no) Fremgangsmaater for stimulering av haarvekst.
AT354613B (de) Werkzeug zur chirurgischen vorbereitung der implantation eines implantats zur befestigung von festsitzendem zahnersatz
DE3777253D1 (de) Herzschrittmacher zur stimulierung des menschlichen herzens.
TR25032A (tr) DOGAL BIR KEMIK DOKUDAN OSTEOPLASTI ICIN GEREKLI BIR MADDENIN üRETIMI USULü VE BU USUL ILE ELDE EDILEN MADDE
DE3876877T2 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
ATE163682T1 (de) Respiratorisches syncytiales virus, impstoffe
DE3784693D1 (de) Verwendung von fluticasonpropionat zur herstellung eines praeparats zur behandlung von darmerkrankungen.
DE3855113T2 (de) Verwendung von Buspiron zur Herstellung eines pharmazeutischen Präparats zur Behandlung der Alkoholsucht
EP0061138A3 (en) Angiotropins of leukocytes and inflamed tissue: a new class of natural chemotropic protein mitogens for specific induction of directional growth of blood vessels, neovascularization of tissues and morphogenesis of blood vessel patterns, process for their biotechnical preparation and pharmaceutical compositions
SE7902742L (sv) Disubstituerade 3-cefem-4-karboxylsyraderivat samt forfarande for framstellning derav
ES2000034A6 (es) Procedimiento para la preparacion de una vacuna viva contra paperas
BR8202494A (pt) Processo para preparar tecido natural fixo bem como tecido natural fixo valvula cardiaca fixa de suino e tecido fixo de pericardio de bovino adequados para implante
DE3778587D1 (de) Herzschrittmacher zur stimulierung des menschlichen herzens.
HUT42770A (en) Process for preparing novel pyrrolo-benzimidazole derivatives, pyrrolo -benzoxazole derivatives and pyrrolo-benzthiazole derivatives and pharmaceutical compositions comprising the same
ATE192923T1 (de) Verwendung von boswelliasäure zur behandlung von hirntumoren
DE69007065T2 (de) Verwendung von Diadenosin-5',5'''-p1,p4-tetraphosphat zur Herstellung eines Arzneimittels zur Behandlung von Herzkrankheiten.
DE3373978D1 (en) Composition for the care or treatment of the human skin
JPS5545681A (en) 88chloroo66hydroxyy55methylbenzoic acid derivative
DE3772051D1 (de) Prothese zur expansion des hautgewebes.
DE3687233T2 (de) Pharmazeutische zusammensetzungen zur behandlung von hautkrankheiten.
ES2081279T3 (es) Utilizacion de 15-desoxiespergualina como medicamento.
DK162738C (da) Varmesteriliserbart kunstigt organ til blodrensning
DE3061907D1 (en) 6-imidazol-1-yl-3-hydrazino-pyridazines, process for preparing them and medicaments containing them
DE3280419T2 (de) Medizinisches praeparat zur behandlung von hautleiden.
NO154669C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktiv 10-bromsandwicin og 10-bromisosandwicin, samt syreaddisjonssalter derav.